Literature DB >> 16322022

Pyoderma gangrenosum in ulcerative colitis: considerations for an early diagnosis.

K I Papageorgiou1, R G Mathew, M G Kaniorou-Larai, A Yiakoumetis.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16322022      PMCID： PMC1298858          DOI： 10.1136/bmj.331.7528.1323

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

Review 1.  Ulcerative colitis. An epidemiological study based on a regional inception cohort, with special reference to disease course and prognosis.

Authors:  E Langholz
Journal:  Dan Med Bull       Date:  1999-11

Review 2.  Treatment of pyoderma gangrenosum.

Authors:  R K Chow; V C Ho
Journal:  J Am Acad Dermatol       Date:  1996-06       Impact factor: 11.527

3.  The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.

Authors:  C N Bernstein; J F Blanchard; P Rawsthorne; N Yu
Journal:  Am J Gastroenterol       Date:  2001-04       Impact factor: 10.864

Review 4.  Pyoderma gangrenosum: classification and management.

Authors:  F C Powell; W P Su; H O Perry
Journal:  J Am Acad Dermatol       Date:  1996-03       Impact factor: 11.527

Review 5.  Minimizing the risk of post-operative pyoderma gangrenosum.

Authors:  C C Long; J Jessop; M Young; P J Holt
Journal:  Br J Dermatol       Date:  1992-07       Impact factor: 9.302

Review 6.  Pyoderma gangrenosum: a review.

Authors:  S M Schwaegerle; W F Bergfeld; D Senitzer; R T Tidrick
Journal:  J Am Acad Dermatol       Date:  1988-03       Impact factor: 11.527

7.  Pyoderma gangrenosum: a review of 86 patients.

Authors:  F C Powell; A L Schroeter; W P Su; H O Perry
Journal:  Q J Med       Date:  1985-05
  7 in total
  1 in total

Review 1.  Neutrophilic folliculitis and the spectrum of pyoderma gangrenosum in inflammatory bowel disease.

Authors:  A P Ruhl; J E Ganz; S J Bickston
Journal:  Dig Dis Sci       Date:  2006-12-08       Impact factor: 3.487
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.